Invest in the Future of Diabetes Care
We’re developing a stem cell-based cure for diabetes using reprogrammed/differentiated cells from the patient’s own body.
Our approach eliminates the need for insulin and lifelong medications, and we’re preparing for our first preclinical trial.
Why Now
Diabetes affects over 500 million people worldwide, with healthcare costs topping $850B annually.
Current treatments manage symptoms, but don’t address the root cause.
Our approach has the potential to reverse disease, not just slow it down.
Why Us
Co-founded by one of the few scientists worldwide with expertise in beta cell differentiation.
Backed by early scientific validation (in vitro and in vivo results from small animal models), patent filings, and partnerships with leading medical clinics.
Our soft launch generated paying clients of our stem cell storage service and investor interest. Now we’re scaling.
What We’re Raising
We’re currently fundraising to fund our next phase of development, including a preclinical pig trial, regulatory advancement, and commercial readiness.
Let’s Talk
If you’re an investor, fund, or strategic partner interested in shaping the future of diabetes care, we’d love to connect.